PHAT icon

Phathom Pharmaceuticals
PHAT

Overview Fund Activity

76 hedge funds and large institutions have $815M invested in Phathom Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
+18
Holders Change %
+31.03%
% of All Funds
1.35%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.09%
New
24
Increased
22
Reduced
15
Closed
5
Calls
$359K
Puts
$491K
Net Calls
-$132K
Net Calls Change
-$132K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
$47.9M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
$64.4M
3
Ensign Peak Advisors
Ensign Peak Advisors
Utah
$40.7M
4
JG
Jefferies Group
New York
$8.22M
5
RPAM
Rhenman & Partners Asset Management
Sweden
$5.81M

Top Sellers

1
BI
BVF Inc
California
$5.01M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$2.69M
3
HLA
Hamilton Lane Advisors
Pennsylvania
$0
4
Invesco
Invesco
Georgia
$68.2M
5
MPAM
Monarch Partners Asset Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
HLA
76
Hamilton Lane Advisors
Pennsylvania
– -$1.17M -31,922 Closed
MPAM
77
Monarch Partners Asset Management
Massachusetts
– -$782K -21,325 Closed
Massachusetts Financial Services
78
Massachusetts Financial Services
Massachusetts
– -$614K -16,755 Closed
PNC Financial Services Group
79
PNC Financial Services Group
Pennsylvania
– -$3K -85 Closed
1 2 3
4